Jan 24 (Reuters) - Canadian marijuana producer Aurora Cannabis ACB.TO on Wednesday agreed to buy CanniMed Therapeutics Inc CMED.TO for about C$1.1 billion ($892.21 million), gearing up to meet an expected surge in demand at home and globally.
CanniMed shareholders will receive either 3.40 Aurora shares for each CanniMed share they hold, or a combination of cash and share, the companies said. will also terminate its agreement to buy Newstrike Resources Ltd HIP.V . ($1 = 1.2329 Canadian dollars)